PL2263680T3 - Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity - Google Patents

Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity

Info

Publication number
PL2263680T3
PL2263680T3 PL10177007T PL10177007T PL2263680T3 PL 2263680 T3 PL2263680 T3 PL 2263680T3 PL 10177007 T PL10177007 T PL 10177007T PL 10177007 T PL10177007 T PL 10177007T PL 2263680 T3 PL2263680 T3 PL 2263680T3
Authority
PL
Poland
Prior art keywords
electrolytes
compressed pharmaceutical
peg
pharmaceutical compositions
polyethylene glycol
Prior art date
Application number
PL10177007T
Other languages
English (en)
Inventor
Norman Barras
Ian Cox
Original Assignee
Norgine Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norgine Bv filed Critical Norgine Bv
Publication of PL2263680T3 publication Critical patent/PL2263680T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL10177007T 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity PL2263680T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0409104.7A GB0409104D0 (en) 2004-04-23 2004-04-23 Compressed pharmaceutical compositions
EP05735983A EP1742645B1 (en) 2004-04-23 2005-04-25 Compressed pharmaceutical compositions comprising peg and electrolytes
EP10177007.1A EP2263680B1 (en) 2004-04-23 2005-04-25 Compressed pharmaceutical compositions comprising peg and electrolytes

Publications (1)

Publication Number Publication Date
PL2263680T3 true PL2263680T3 (pl) 2015-02-27

Family

ID=32344298

Family Applications (2)

Application Number Title Priority Date Filing Date
PL10177007T PL2263680T3 (pl) 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity
PL05735983T PL1742645T3 (pl) 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL05735983T PL1742645T3 (pl) 2004-04-23 2005-04-25 Sprasowane kompozycje farmaceutyczne zawierające PEG i elektrolity

Country Status (22)

Country Link
US (1) US20070298100A1 (pl)
EP (2) EP2263680B1 (pl)
JP (1) JP2007533719A (pl)
KR (1) KR20070001280A (pl)
CN (1) CN1950097A (pl)
AT (1) ATE496626T1 (pl)
AU (1) AU2005235345B8 (pl)
BR (1) BRPI0510175A (pl)
CA (1) CA2561649C (pl)
DE (1) DE602005026117D1 (pl)
DK (2) DK1742645T3 (pl)
ES (2) ES2519540T3 (pl)
GB (1) GB0409104D0 (pl)
IL (1) IL178722A0 (pl)
MX (1) MXPA06011906A (pl)
NO (1) NO20064780L (pl)
PL (2) PL2263680T3 (pl)
PT (2) PT1742645E (pl)
RU (1) RU2006137347A (pl)
SI (2) SI1742645T1 (pl)
WO (1) WO2005102364A1 (pl)
ZA (1) ZA200608496B (pl)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006244112B2 (en) * 2005-05-06 2011-02-17 Salix Pharmaceuticals, Inc. Polyethylene glycol colonic purgative composition
ES2278537B1 (es) * 2006-01-30 2008-09-16 Laboratorios Casen-Fleet, S.L. Procedimiento de fabricacion de una solucion a base de polietilenglicol con electrolitos, producto obtenido y uso.
US8784872B2 (en) * 2007-11-19 2014-07-22 Comgenrx, Inc. Formulation for decreasing tobacco, alcohol, drug or food consumption
US20090130048A1 (en) * 2007-11-19 2009-05-21 Oronsky Bryan Todd Topical Composition for Treating Pain
WO2009146782A1 (de) 2008-06-06 2009-12-10 Roto Frank Ag Ausstellvorrichtung für ein fenster, eine tür oder dergleichen
WO2009158667A2 (en) * 2008-06-27 2009-12-30 Comgenrx, Inc. Povidone compositions for wound healing
DK2421373T3 (da) * 2009-04-21 2019-12-16 Dale R Bachwich Tarmrensningssystem
NZ596604A (en) * 2009-06-03 2014-04-30 Aptalis Pharma Us Inc L-sugar colon cleansing agent and uses thereof
GB0913295D0 (en) * 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
AU2010328366A1 (en) * 2009-12-07 2012-06-21 Aptalis Pharma Us, Inc Methods for purifying monosaccharide mixtures containing ionic impurities
CN101766648B (zh) * 2010-03-02 2012-01-11 舒泰神（北京）生物制药股份有限公司 聚乙二醇电解质颗粒制剂及其制造方法
DE202010012256U1 (de) * 2010-09-07 2010-11-11 Krewel Meuselbach Gmbh Abführmittel
US20130225692A1 (en) * 2010-11-04 2013-08-29 Peter Stein Formulations comprising polyethylene glycol
AU2011100528B4 (en) * 2011-05-10 2011-08-25 Norgine Bv Formulations
DE202010016235U1 (de) 2010-12-06 2011-05-19 Norgine B.V. Formulierungen
IES20110480A2 (en) * 2010-11-04 2012-07-18 Norgine Bv A solid formulation for oral administration comprising polyethylene glycol and mannitol
RU2651751C2 (ru) 2011-01-28 2018-04-23 Уильям А. ШЕЙВЕР Способ, композиция и набор для чистки кишечника
KR101852502B1 (ko) * 2011-01-31 2018-04-26 노어긴 비.브이. 조성물에 관한 개선
TWI535461B (zh) * 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
CN102133225B (zh) * 2011-03-18 2012-11-21 海南锦瑞制药股份有限公司 一种复方聚乙二醇电解质散剂及其制备方法
IN2014DN03373A (pl) * 2011-10-27 2015-06-05 Borody Thomas J
CN102600201B (zh) * 2012-02-07 2014-07-16 舒泰神（北京）生物制药股份有限公司 用于通便和清肠的药物组合物及其制备方法
KR20170098980A (ko) 2012-09-11 2017-08-30 노어긴 비.브이. Peg 및 아스코르베이트를 포함하는 조성물
CA2903283C (en) * 2013-03-15 2023-09-05 Braintree Laboratories, Inc. Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
EA201692106A1 (ru) * 2014-04-29 2017-04-28 КОЛОНАРИКОНСЕПТС ЭлЭлСи Пищевые продукты, системы, способы и наборы для замены электролитов
US10350165B2 (en) 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
IL252881B (en) * 2014-12-12 2022-06-01 Ojai Energetics Pbc Microencapsulated cannabinoid preparations
FR3056109B1 (fr) * 2016-09-21 2019-10-11 Pierre Fabre Medicament Utilisation de formulations solides de polyethylene glycol dans le traitement de la constipation
CN107028876B (zh) * 2016-10-09 2020-09-29 舒泰神（北京）生物制药股份有限公司 聚乙二醇电解质口服液及其制备方法
US11339264B2 (en) 2017-07-20 2022-05-24 Solvay Sa Functionalized particulate bicarbonate as blowing agent, foamable polymer composition containing it, and its use in manufacturing a thermoplastic foamed polymer
KR101981069B1 (ko) 2018-02-01 2019-05-22 주식회사태준제약 장세척 조성물
WO2019151829A1 (ko) * 2018-02-01 2019-08-08 주식회사태준제약 장세척 조성물
CN110433174A (zh) * 2019-07-17 2019-11-12 华南理工大学 一种高依从性的复方聚乙二醇电解质散剂及其制备方法与应用
CN111617102B (zh) * 2020-05-25 2022-05-31 南京金凯木纳米材料有限公司 一种含聚乙二醇的电解质散剂及其制备方法
WO2022093170A1 (en) * 2020-10-26 2022-05-05 Braintree Laboratories, Inc. Sulfate salt formulations for colon cleansing

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121663A (en) * 1956-02-09 1964-02-18 Plough Lab Inc Carbon dioxide releasing laxative suppository
US5229132A (en) * 1985-02-22 1993-07-20 Grimberg Georges Serge Non-absorbable gastrointestinal medicament provided for treating the two levels of the digestive tract at the same time
AU6196786A (en) * 1985-08-01 1987-03-05 Braintree Laboratories Inc. Low-sodium laxative and lavage formulation
US5273758A (en) * 1991-03-18 1993-12-28 Sandoz Ltd. Directly compressible polyethylene oxide vehicle for preparing therapeutic dosage forms
US6121663A (en) * 1997-05-22 2000-09-19 Advanced Micro Devices, Inc. Local interconnects for improved alignment tolerance and size reduction
FR2784897B1 (fr) * 1998-10-27 2002-11-29 Agronomique Inst Nat Rech Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux
US6444198B1 (en) * 1999-02-22 2002-09-03 Smithkline Beecham Corporation Effervescent laxatives
DE19933148A1 (de) * 1999-07-20 2001-01-25 Boehringer Ingelheim Int Ambroxolhaltige Lutschtablette
JP2007511610A (ja) * 2003-11-17 2007-05-10 ブレーントリー ラボラトリーズ インコーポレーティッド 治療用ｐｅｇ溶液濃縮物
US7687075B2 (en) * 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent

Also Published As

Publication number Publication date
ES2519540T3 (es) 2014-11-07
CA2561649A1 (en) 2005-11-03
AU2005235345B2 (en) 2011-04-14
EP1742645A1 (en) 2007-01-17
ES2361816T3 (es) 2011-06-22
PT1742645E (pt) 2011-04-29
ATE496626T1 (de) 2011-02-15
DK1742645T3 (da) 2011-05-09
JP2007533719A (ja) 2007-11-22
GB0409104D0 (en) 2004-05-26
SI2263680T1 (sl) 2015-01-30
CA2561649C (en) 2014-10-14
AU2005235345B8 (en) 2011-05-12
PT2263680E (pt) 2014-11-19
US20070298100A1 (en) 2007-12-27
SI1742645T1 (sl) 2011-05-31
MXPA06011906A (es) 2007-01-25
AU2005235345A1 (en) 2005-11-03
DE602005026117D1 (de) 2011-03-10
EP1742645B1 (en) 2011-01-26
ZA200608496B (en) 2008-07-30
KR20070001280A (ko) 2007-01-03
PL1742645T3 (pl) 2011-06-30
NO20064780L (no) 2007-01-18
IL178722A0 (en) 2007-02-11
EP2263680A1 (en) 2010-12-22
BRPI0510175A (pt) 2007-10-02
EP2263680B1 (en) 2014-08-27
DK2263680T3 (en) 2014-12-08
RU2006137347A (ru) 2008-05-27
CN1950097A (zh) 2007-04-18
WO2005102364A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
IL178722A0 (en) Compressed pharmaceutical compositions comprising peg and electrolytes
WO2006105001A3 (en) Lubricant compositions, condom products and methods of making same
IL176005A0 (en) 2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
EP2415760A3 (en) CCR-9 antagonists
WO2007039825A3 (en) Saccharide foamable compositions
CA2525874A1 (en) Pharmaceutical compositions of varenicline
WO2008036932A3 (en) Compositions and methods comprising boswellia species
IL163552A (en) Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same
PL1758553T3 (pl) Kompozycje farmaceutyczne zawierające glikol polietylenowy o masie cząsteczkowej niższej niż 600 Daltonów
IL183044A0 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
WO2007044809A3 (en) Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use
WO2007057714A3 (en) Pharmaceutical compositions comprising methotrexate
WO2006052876A3 (en) Insecticidal compositions suitable for use in preparation of insecticidal granular fertilizer and insecticidal formulations
GB0410616D0 (en) Antiperspirant or deodorant compositions
ID28705A (id) Komposisi yang terdiri dari asam askorbat dan pektin
WO2005092362A3 (de) Pharmazeutisches kombinationspräparat enthaltend ein therapeutisches protein
MX2009005205A (es) Conjugado de polietilenglicol-g-csf.
WO2003020265A3 (en) Compositions comprising pectin and ascorbic acid
MY133230A (en) Combination of no synthase inhibitor(s) and metabolic antioxidant(s)
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje
IL191560A0 (en) 3,4-dihydrobenzoxazine derivatives and pharmaceutical compositions containing the same
WO2005072736A3 (en) Stable gabapentin compositions
ATE442057T1 (de) Interessante nährstoff- und organoleptische eigenschaften zeigende lipidische zusammensetzung
TW200511986A (en) Antifungal composition
HRP20040718A2 (en) Medicinal composition containing 2,2-dichloro-12-(4-chlorophenyl)dodecanoic acid